Editorial Policy

No clinical credential is claimed here

Nothing on this site is medical advice. It is consumer comparison writing about companies that sell peptide therapy, and about what has been published on the compounds they sell.

No clinician writes here, and no page is medically reviewed. Editorial work is signed by a standards editor, a role that owns the ranking rubric, the evidence grades, and the price verification dates. It claims no license to practice medicine and no clinical judgment.

Whether to take a compound, and at what dose, is a decision for a prescriber who knows your history. Your dose instructions come from that prescriber and the leaflet in your carton.

What an evidence grade measures, and what it does not

An evidence grade describes the published human evidence for the uses a compound is marketed for. It is not a ruling on whether a molecule works.

There are three tiers, and each is printed as a word: strong evidence, limited evidence, and no controlled human evidence. The word carries the meaning. Color carries none of it, because a red and green meter would read as a safety warning, which is a different claim entirely.

The distinction matters most where one molecule has two lives. PT-141 is graded no controlled human evidence here, even though the same molecule, under the name bremelanotide, stands behind an approved product for one narrow indication.

That is deliberate. The trials behind the approved product were run for a use that peptide storefronts do not advertise, and grading the marketed use rather than the molecule is what keeps the grade honest.

The rule cuts both ways, because a grade of no controlled human evidence is not a claim that a compound is dangerous or useless. It reports what has been measured and published, and stops there.

Where the published literature does not support a trial count, no count is printed, because a zero is not itself a citation.

Regulatory status is dated and stated, never predicted

Where a compound has a regulatory status worth stating, the page states what happened, which body acted, and the date it was true.

No page here predicts an outcome, a deadline, or the odds of one. No timelines, no likelihoods, no reading of which way a decision will go.

When a status changes, the dated entry changes with it. A reader can check the date and judge how fresh it is.

An FDA warning letter is disclosed, and never disqualifying

A warning letter is disclosed on the provider's review, along with what the letter actually concerned. It never moves a score, a rank, or a verdict.

The large majority of letters in this market concern marketing and labeling claims, meaning how a product was promoted or presented. They are not findings about the contents of a vial.

Treating a letter as a safety finding would tell readers something the letter does not say. Disclosing it plainly, and letting the reader weigh it, tells them something true.

A letter is also not a license to comment on a company's character. The page says what the letter was about, and leaves the reader to decide what it is worth.

A board with no providers is published on purpose

Some compound boards carry no provider rows at all, and that is the finding rather than a gap in the site.

A board fills in when a seller can be shown to publish what the rubric asks for. Where no seller can, the board publishes empty and explains why.

Padding a board with sellers that cannot be shown to be compliant would earn more clicks and be worth less to the reader. An empty board is the more useful answer, so it stays empty.

The provider score and the evidence grade are separate measurements

The provider score grades a seller's disclosure. The evidence grade describes a compound's published human evidence. They answer different questions and are never merged into one number.

A careful seller can score well while selling a compound with thin evidence behind it. A page has to be able to say both things at once without contradicting itself, so it does.

The rubric behind the score is set out on the methodology page.

Numbers, sources, and quotations

Every number a page prints is a recorded field with a source and a date behind it, not a figure pulled out of prose.

No statistic appears unless a source states it. A total that a source does not state is not printed as a total.

Quotations come from the source being quoted, read on the day recorded. A right number with a wrong citation is still an error, and it is treated as one.

Independence from the companies covered

No provider previews a page, approves a score, or sees a draft before it publishes.

Commercial relationships are computed from the provider list and disclosed on every page carrying a call to action. The full disclosure explains what a commission does and does not buy.

Corrections

Errors get fixed, the fix is dated, and anyone can report one, including a company writing about itself.

The corrections page explains what to send and what happens next.